Specifically, NID1 was related to open chromatin regions in both the LGG and GBM samples, demonstrating the different functions of genes between the two glioma subtypes and further confirming the diversity of gene transcription regulation between them. This evidence concerns the gene NID1 and central nervous system cancer.